We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.39B
1-Year Est. Return 1.06%
This Fund
S&P 500
This Quarter Est. Return
+3.61%
1 Year Est. Return
-1.06%
3 Year Est. Return
+72.63%
5 Year Est. Return
+112.03%
10 Year Est. Return
+415.67%
AUM
$3.12B
AUM Growth
+$70.9M
Cap. Flow
-$7.14M
Cap. Flow %
-0.23%
Top 10 Hldgs %
60.9%
Holding
446
New
17
Increased
238
Reduced
30
Closed
6

Top Buys

Rank Stock Value
1
CARG icon
CarGurus
CARG
+$7.14M
2
UNP icon
Union Pacific
UNP
+$2.36M
3
SCHW
Charles Schwab
SCHW
+$2.28M
4
LOW icon
Lowe's Companies
LOW
+$2.26M
5
NOC icon
Northrop Grumman
NOC
+$2.2M

Sector Composition

Rank Sector Weight
1 Healthcare 41.64%
2 Technology 10.83%
3 Communication Services 9.24%
4 Utilities 7.74%
5 Consumer Discretionary 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMCL icon
401
Omnicell
OMCL
$1.69B
$15K ﹤0.01%
+85
New +$14.7K
UMC icon
402
United Microelectronic
UMC
$47.5B
$15K ﹤0.01%
1,276
GAP
403
The Gap Inc
GAP
$7.34B
$15K ﹤0.01%
834
+4
+0.5% +$84
HUBS icon
404
HubSpot
HUBS
$11.9B
$14K ﹤0.01%
+22
New +$16.6K
KDP icon
405
Keurig Dr Pepper
KDP
$43B
$14K ﹤0.01%
372
+1
+0.3% +$35
SLNO
406
DELISTED
Soleno Therapeutics
SLNO
$14K ﹤0.01%
2,288
AR icon
407
Antero Resources
AR
$10.9B
$13K ﹤0.01%
+750
New +$14.2K
OTIC
408
DELISTED
Otonomy, Inc.
OTIC
$13K ﹤0.01%
6,442
MYO icon
409
Myomo
MYO
$38.6M
$11K ﹤0.01%
1,570
SIEN
410
DELISTED
Sientra, Inc.
SIEN
$11K ﹤0.01%
308
CDTX
411
DELISTED
Cidara Therapeutics
CDTX
$10K ﹤0.01%
387
SGMO
412
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$10K ﹤0.01%
1,273
PRTK
413
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$10K ﹤0.01%
2,159
EWJ icon
414
iShares MSCI Japan ETF
EWJ
$22.1B
$8K ﹤0.01%
125
+1
+0.8% +$68
LAB icon
415
Standard BioTools
LAB
$351M
$8K ﹤0.01%
1,975
RDWR icon
416
Radware
RDWR
$1.05B
$8K ﹤0.01%
+200
New +$6.8K
JNCE
417
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$8K ﹤0.01%
1,009
DELL icon
418
Dell
DELL
$262B
$7K ﹤0.01%
119
-116
-49% -$6.47K
FPI
419
Farmland Partners
FPI
$411M
$7K ﹤0.01%
+576
New +$6.86K
XRX icon
420
Xerox
XRX
$456M
$7K ﹤0.01%
312
-450
-59% -$9.14K
ESPR
421
DELISTED
Esperion Therapeutics
ESPR
$6K ﹤0.01%
1,121
HPQ icon
422
HP
HPQ
$24.6B
$6K ﹤0.01%
171
+2
+1% +$65
KRRO icon
423
Korro Bio
KRRO
$151M
$6K ﹤0.01%
22
CTMX icon
424
CytomX Therapeutics
CTMX
$714M
$3K ﹤0.01%
712
HPE icon
425
Hewlett Packard
HPE
$62.4B
$3K ﹤0.01%
165
+1
+0.6% +$15

Similar funds

Bollard Group's Q4 2021 Portfolio in Review

As of Q4 2021, Bollard Group held 446 positions worth $3.12B, up 2.3% from $3.05B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Bollard Group's Q4 2021 filing shows 17 new, 238 increased, 30 reduced and 6 closed positions. Its largest new stake was Reservoir Media: 130,000 shares worth $1.03M. The largest sale was Alibaba, an estimated $17.6M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 43% a quarter earlier, followed by Technology and Communication Services.

  • Bollard Group's largest Q4 2021 buy was Reservoir Media: 130,000 shares worth $1.03M.
  • Bollard Group added most to CarGurus in Q4 2021, an estimated $7.14M increase.
  • Bollard Group's biggest Q4 2021 reduction was Alibaba, cutting an estimated $17.6M.
  • Bollard Group fully exited Rocket Companies in Q4 2021, selling an estimated $8.02M.
  • Bollard Group's ten largest holdings make up 61% of its $3.12B portfolio in Q4 2021.
  • Bollard Group opened 17 new positions and closed 6 in Q4 2021.
  • Bollard Group's portfolio value rose 2.3% quarter-over-quarter to $3.12B.

Based on Bollard Group's 13F filing for Q4 2021, filed 11 Feb 2022.